Description
BSE announces the schedule for offer to buy acquisition window for PHARMAIDS PHARMACEUTICALS LTD from August 4-18, 2025 at Rs. 62.15 per share.
Summary
BSE has announced the live activities schedule for the Offer to Buy – Acquisition Window (Takeover) for PHARMAIDS PHARMACEUTICALS LTD. The offer will run from Monday, August 4, 2025 to Monday, August 18, 2025, targeting up to 91,69,632 equity shares at Rs. 62.15 per share.
Key Points
- Security: PHARMAIDS PHARMACEUTICALS LTD (Symbol: PHARMAID, Scrip Code: 524572)
- ISIN: INE117D01018
- Offer size: Up to 91,69,632 equity shares
- Offer price: Rs. 62.15 per share
- Face value: Rs. 10.00
- Market lot: 1 share
- Offer period: August 4-18, 2025
Regulatory Changes
No new regulatory changes introduced. Standard OTB procedures apply as per existing Exchange Notices 20150930-1 and 20170203-29.
Compliance Requirements
- Trading Members must ensure UCC registration with correct PAN and category
- Only investors with shares in demat form can participate
- Members must use designated platforms: iBBS, RTRMS, and Extranet
- Proper bid categorization required (FII, FI, MF, IC, OTH, NOH, CO, IND)
Important Dates
- Bid Offering Period: August 4-18, 2025 (9:15 AM - 3:30 PM)
- Give-up/Take-up Period: August 4-14, 2025 (9:15 AM - 3:30 PM)
- Give-up Last Day: August 18, 2025 (9:15 AM - 3:30 PM)
- Take-up Last Day: August 18, 2025 (9:15 AM - 4:00 PM)
Impact Assessment
Moderate impact limited to PHARMAIDS PHARMACEUTICALS LTD shareholders and related trading activities. The takeover offer provides exit opportunity for existing shareholders at Rs. 62.15 per share. Trading members need to ensure system readiness and client onboarding for participation in the OTB process.
Impact Justification
Specific takeover offer affecting single stock with defined timeline and procedures